Research from Roswell Park Comprehensive Cancer Center in the Area of CD20 Monoclonal Antibodies Published (Carfilzomib Combined with Rituximab, Ifosfamide, Carboplatin, and Etoposide for Relapsed or Refractory DLBCL)

Press/Media

Period	29 Nov 2022

Media coverage

Title	Research from Roswell Park Comprehensive Cancer Center in the Area of CD20 Monoclonal Antibodies Published (Carfilzomib Combined with Rituximab, Ifosfamide, Carboplatin, and Etoposide for Relapsed or Refractory DLBCL)
Media name/outlet	Immunotherapy Daily
Country/Territory	United States
Date	29/11/22
URL	ct.moreover.com/?a=49380497954&p=1gw&v=1&x=MUGiTkdACr0re9k-GZZW2g
Persons	Suchitra Sundaram